CP and Alzheimer disease: These findings suggest that CaAKG holds promise as a therapeutic strategy for AD by enhancing synaptic plasticity and promoting associative plasticity, particularly through mechanisms that involve LTCC, CP‐AMPARs, and autophagy modulation.